Designed to unburden clinics, Telehealth+ offers affordable remote auscultation and diagnostics modules
HENDERSON, NV, USA, Mar 28, 2023 - Medaica, a digital health company, extending the capability of home diagnostics, today launched Telehealth+, a remote auscultation and diagnostics platform, designed to unburden clinics via affordable and simple clinical-grade remote exams.
Telehealth+ comes bundled with the Medaica M1 Telehealth Stethoscope, an FDA-cleared (Note 1) stethoscope for Over-the-Counter (OTC) use by consumers and is available as a complete telehealth system or in modules that are interoperable with existing telehealth systems.
“With Telehealth+ and the FDA-cleared Medaica M1 Telehealth Stethoscope, providers can now extend auscultation to anyone with an internet connected device,” said Stephen Randall, CEO of Medaica. “We envision a new generation of telehealth applications that provide much more than simple video calls. For millions of patients and their providers, clinical-grade exams via what we could call ‘Telehealth 2.0,’ has the power to democratize access to healthcare and help unburden clinics.”
Medaica is a digital health company, extending the reach and capability of home diagnostics. The company’s mission is to enable affordable access to quality healthcare for everyone. Medaica’s products include the FDA-cleared Medaica M1 Telehealth Stethoscope and Medaica Telehealth+, a digital diagnostics and telehealth platform. Medaica is headquartered in Henderson, Nevada, with offices in London and Madrid.
For more information visit: www medaica.com
Medaica, Medaica Telehealth+ and Medaica M1 Telehealth Stethoscope are trademarks of Medaica Inc.
Media Contact: Stephen Randall,